文献速递神经肿瘤

非增强T2加权磁共振成像序列用于无症状凸面脑膜瘤的长期监测

Noncontrast T2-Weighted Magnetic Resonance Imaging Sequences for Long-Term Monitoring of Asymptomatic Convexity Meningiomas.
PubMed 文献 · World Neurosurg · 2019-11-14

该回顾性病历回顾纳入18例无症状脑膜瘤患者的106个MRI序列,比较非增强T2及T2 FLAIR与增强T1序列测量肿瘤大小变化,并与神经外科医生和神经放射科医生的定性共识判读对比。结果显示17/18例患者非增强测量与共识一致,仅1例T2提示11%增长而T2 FLAIR及共识为稳定。作者认为非增强MRI在监测无症状脑膜瘤肿瘤大小变化方面与增强MRI等效。

要点

  • 非增强T2及T2 FLAIR序列在17/18例患者中与共识判读一致。
  • 1例患者T2提示11%增长,而T2 FLAIR及共识判读为稳定。
  • 作者认为非增强MRI在监测无症状脑膜瘤大小变化方面与增强MRI等效。

核心结论

  • 作者认为非增强MRI扫描在随访无症状脑膜瘤肿瘤大小随时间变化方面与增强MRI扫描等效。

研究设计与样本

  • 经机构审查委员会批准的回顾性病历回顾,纳入18例患者的106个MRI序列。
  • 纳入标准为成人无症状脑膜瘤患者,且接受基线增强和非增强轴位脑MRI扫描。
  • 排除标准包括:基线或随访轴位图像不可用于回顾、基线扫描未使用增强、脑膜瘤诊断不确定。

主要发现

  • 以测量变化大于10%代表肿瘤生长。
  • 18例患者中17例的非增强检查(T2和T2 FLAIR)测量与共识一致。
  • 1例患者T2成像提示11%生长,而T2 FLAIR和总体共识为稳定。

关键数值与推荐

  • 肿瘤生长定义为测量变化大于10%。
  • 通过比较最早和最近扫描的最大肿瘤直径横截面积来测量肿瘤生长百分比。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gadolinium-based contrast agents (GBCAs) used to enhance magnetic resonance imaging (MRI) scans have been linked to tissue deposition, including in the brain. The management of indolent tumors such as meningiomas requires frequent MRI scans to monitor for interval growth. Given concern regarding GBCA deposition, we sought to determine if noncontrast MRI scans in patients with asymptomatic meningiomas were equivalent to GBCA-enhanced MRI scans in surveillance monitoring. METHODS: This institutional review board-approved retrospective chart review included 106 MRI sequences from 18 patients. Inclusion criteria were adult patients with asymptomatic meningiomas who received baseline contrast-enhanced and noncontrast axial brain MRI scan. Exclusion criteria included the following: 1) baseline or follow-up axial images were not available for review, 2) baseline scan was obtained without contrast, and 3) diagnosis of meningioma was uncertain. Percent tumor growth was measured by comparing cross-sectional area at maximum tumor diameter from the earliest and most recent scans. For each patient, change in tumor size over time was compared using T1 + contrast, T2, and T2 fluid-attenuated inversion recovery (FLAIR) sequences. These were compared with a qualitative consensus reading by a neurosurgeon and a neuroradiologist. RESULTS: Measured change of greater than 10% was taken to represent tumor growth. In 17 out of 18 patients, measurement of noncontrast studies (T2 and T2 FLAIR) matched consensus. For one patient, imaging on T2 suggested 11% growth, whereas T2 FLAIR and overall consensus was stability. CONCLUSIONS: Our study provides evidence that noncontrasted MRI scans are equivalent to contrast-weighted MRI scans to follow change in tumor size over time in asymptomatic meningiomas.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. He JQ, Iv M, Li G, et al. Noncontrast T2-Weighted Magnetic Resonance Imaging Sequences for Long-Term Monitoring of Asymptomatic Convexity Meningiomas. World Neurosurg. 2019. PMID: 31734418. doi:10.1016/j.wneu.2019.11.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。